Mackenzie Financial Corp Merck & Co., Inc. Transaction History
Mackenzie Financial Corp
- $63.2 Billion
- Q2 2024
A detailed history of Mackenzie Financial Corp transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mackenzie Financial Corp holds 2,339,106 shares of MRK stock, worth $266 Million. This represents 0.46% of its overall portfolio holdings.
Number of Shares
2,339,106
Previous 2,189,127
6.85%
Holding current value
$266 Million
Previous $289 Million
0.25%
% of portfolio
0.46%
Previous 0.44%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,830Shares Held
1.91BCall Options Held
13.4MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA245MShares$27.8 Billion0.59% of portfolio
-
Black Rock Inc. New York, NY207MShares$23.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA117MShares$13.4 Billion0.65% of portfolio
-
Wellington Management Group LLP Boston, MA72.5MShares$8.24 Billion1.64% of portfolio
-
Geode Capital Management, LLC Boston, MA57MShares$6.48 Billion0.63% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $288B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...